Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 322
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Cocchi, Enrico Fabbri, Chiara Han, Changsu Lee, Soo-Jung Patkar, Ashwin A. Masand, Prakash S. Pae, Chi-Un and Serretti, Alessandro 2016. Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway. BMC Psychiatry, Vol. 16, Issue. 1,

    de Jong, Marasha Lazar, Sara W. Hug, Kiran Mehling, Wolf E. Hölzel, Britta K. Sack, Alexander T. Peeters, Frenk Ashih, Heidi Mischoulon, David and Gard, Tim 2016. Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression. Frontiers in Psychology, Vol. 7,

    Dutra, Sunny J. Siegle, Greg J. Reeves, Elizabeth J. Mauss, Iris B. and Gruber, June 2016. Feeling Without Thinking? Anger Provocation Task Predicts Impaired Cognitive Performance in Bipolar Disorder but not Major Depression or Healthy Adults. Cognitive Therapy and Research, Vol. 40, Issue. 2, p. 139.

    Feng, Yuan Huang, Wei Tian, Teng-Fei Wang, Gang Hu, Chen Chiu, Helen F.K. Ungvari, Gabor S. Kilbourne, Amy M. and Xiang, Yu-Tao 2016. The psychometric properties of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) and the Patient Health Questionnaire-9 (PHQ-9) in depressed inpatients in China. Psychiatry Research, Vol. 243, p. 92.

    Fuhr, Kristina Hautzinger, Martin Krisch, Katharina Berking, Matthias and Ebert, David Daniel 2016. Validation of the Behavioral Activation for Depression Scale (BADS)—Psychometric properties of the long and short form. Comprehensive Psychiatry, Vol. 66, p. 209.

    Furukawa, Toshi A Schramm, Elisabeth Weitz, Erica S Salanti, Georgia Efthimiou, Orestis Michalak, Johannes Watanabe, Norio Cipriani, Andrea Keller, Martin B Kocsis, James H Klein, Daniel N and Cuijpers, Pim 2016. Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis. BMJ Open, Vol. 6, Issue. 5, p. e011769.

    Geddes, John R Gardiner, Alexandra Rendell, Jennifer Voysey, Merryn Tunbridge, Elizabeth Hinds, Christopher Yu, Ly-Mee Hainsworth, Jane Attenburrow, Mary-Jane Simon, Judit Goodwin, Guy M and Harrison, Paul J 2016. Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. The Lancet Psychiatry, Vol. 3, Issue. 1, p. 31.

    Greer, Tracy L. Trombello, Joseph M. Rethorst, Chad D. Carmody, Thomas J. Jha, Manish K. Liao, Allen Grannemann, Bruce D. Chambliss, Heather O. Church, Timothy S. and Trivedi, Madhukar H. 2016. IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY. Depression and Anxiety,

    Grove, Tyler B. Tso, Ivy F. Chun, Jinsoo Mueller, Savanna A. Taylor, Stephan F. Ellingrod, Vicki L. McInnis, Melvin G. and Deldin, Patricia J. 2016. Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis. Psychiatry Research, Vol. 243, p. 198.

    Gruber, June Siegel, Erika H. Purcell, Amanda L. Earls, Holly A. Cooper, Gaia and Barrett, Lisa Feldman 2016. Unseen positive and negative affective information influences social perception in bipolar I disorder and healthy adults. Journal of Affective Disorders, Vol. 192, p. 191.

    Guardado, Pedro Olivera, Anlys Rusch, Heather L. Roy, Michael Martin, Christiana Lejbman, Natasha Lee, Hwyunhwa and Gill, Jessica M. 2016. Altered gene expression of the innate immune, neuroendocrine, and nuclear factor-kappa B (NF-κB) systems is associated with posttraumatic stress disorder in military personnel. Journal of Anxiety Disorders, Vol. 38, p. 9.

    Gyurak, Anett Patenaude, Brian Korgaonkar, Mayuresh S. Grieve, Stuart M. Williams, Leanne M. and Etkin, Amit 2016. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression. Biological Psychiatry, Vol. 79, Issue. 4, p. 274.

    Haroon, E Fleischer, C C Felger, J C Chen, X Woolwine, B J Patel, T Hu, X P and Miller, A H 2016. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Molecular Psychiatry,

    Harvey, Allison G. Lee, Jason Smith, Rita L. Gumport, Nicole B. Hollon, Steven D. Rabe-Hesketh, Sophia Hein, Kerrie Dolsen, Michael R. Haman, Kirsten L. Kanady, Jennifer C. Thompson, Monique A. and Abrons, Deidre 2016. Improving outcome for mental disorders by enhancing memory for treatment. Behaviour Research and Therapy, Vol. 81, p. 35.

    Huffman, Jeff C. Boehm, Julia K. Beach, Scott R. Beale, Eleanor E. DuBois, Christina M. and Healy, Brian C. 2016. Relationship of optimism and suicidal ideation in three groups of patients at varying levels of suicide risk. Journal of Psychiatric Research, Vol. 77, p. 76.

    Huijbers, Marloes J. Spinhoven, Philip van Schaik, Digna J.F. Nolen, Willem A. and Speckens, Anne E.M. 2016. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness. Journal of Affective Disorders, Vol. 195, p. 32.

    Huijbers, M. J. Spinhoven, P. Spijker, J. Ruhe, H. G. van Schaik, D. J. F. van Oppen, P. Nolen, W. A. Ormel, J. Kuyken, W. van der Wilt, G. J. Blom, M. B. J. Schene, A. H. Rogier, A. Donders, T. and Speckens, A. E. M. 2016. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial. The British Journal of Psychiatry, Vol. 208, Issue. 4, p. 366.

    Jha, Manish K. Greer, Tracy L. Grannemann, Bruce D. Carmody, Thomas Rush, A. John and Trivedi, Madhukar H. 2016. Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial. Journal of Affective Disorders, Vol. 206, p. 17.

    Joshi, Shantanu H. Espinoza, Randall T. Pirnia, Tara Shi, Jie Wang, Yalin Ayers, Brandon Leaver, Amber Woods, Roger P. and Narr, Katherine L. 2016. Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression. Biological Psychiatry, Vol. 79, Issue. 4, p. 282.

    Kendrick, Tony El-Gohary, Magdy Stuart, Beth Gilbody, Simon Churchill, Rachel Aiken, Laura Bhattacharya, Abhishek Gimson, Amy Brütt, Anna L de Jong, Kim Moore, Michael and Kendrick, Tony 2016. Cochrane Database of Systematic Reviews.


The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation

  • M. H. TRIVEDI (a1), A. J. RUSH (a1), H. M. IBRAHIM (a1), T. J. CARMODY (a1), M. M. BIGGS (a1), T. SUPPES (a1), M. L. CRISMON (a1), K. SHORES-WILSON (a1), M. G. TOPRAC (a1), E. B. DENNEHY (a1), B. WITTE (a1) and T. M. KASHNER (a1)
  • DOI:
  • Published online: 14 January 2004

Background. The present study provides additional data on the psychometric properties of the 30-item Inventory of Depressive Symptomatology (IDS) and of the recently developed Quick Inventory of Depressive Symptomatology (QIDS), a brief 16-item symptom severity rating scale that was derived from the longer form. Both the IDS and QIDS are available in matched clinician-rated (IDS-C30; QIDS-C16) and self-report (IDS-SR30; QIDS-SR16) formats.

Method. The patient samples included 544 out-patients with major depressive disorder (MDD) and 402 out-patients with bipolar disorder (BD) drawn from 19 regionally and ethnicically diverse clinics as part of the Texas Medication Algorithm Project (TMAP). Psychometric analyses including sensitivity to change with treatment were conducted.

Results. Internal consistencies (Cronbach's alpha) ranged from 0·81 to 0·94 for all four scales (QIDS-C16, QIDS-SR16, IDS-C30 and IDS-SR30) in both MDD and BD patients. Sad mood, involvement, energy, concentration and self-outlook had the highest item-total correlations among patients with MDD and BD across all four scales. QIDS-SR16 and IDS-SR30 total scores were highly correlated among patients with MDD at exit (c=0·83). QIDS-C16 and IDS-C30 total scores were also highly correlated among patients with MDD (c=0·82) and patients with BD (c=0·81). The IDS-SR30, IDS-C30, QIDS-SR16, and QIDS-C16 were equivalently sensitive to symptom change, indicating high concurrent validity for all four scales. High concurrent validity was also documented based on the SF-12 Mental Health Summary score for the population divided in quintiles based on their IDS or QIDS score.

Conclusion. The QIDS-SR16 and QIDS-C16, as well as the longer 30-item versions, have highly acceptable psychometric properties and are treatment sensitive measures of symptom severity in depression.

Corresponding author
Dr Madhukar H. Trivedi, University of Texas, Southwestern Medical Center, Department of Psychiatry, Depression and Anxiety Disorders Program, St Paul Professional Building I, 5959 Harry Hines Boulevard, Suite 600, Dallas, TX 75235, USA.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *